Suppr超能文献

一种工程化的精氨酸残基具有异常的 pH 敏感性反应性,有助于抗体的位点选择性偶联。

An Engineered Arginine Residue of Unusual pH-Sensitive Reactivity Facilitates Site-Selective Antibody Conjugation.

出版信息

Biochemistry. 2021 Apr 13;60(14):1080-1087. doi: 10.1021/acs.biochem.0c00955. Epub 2021 Mar 23.

Abstract

Monoclonal antibody h38C2 is a humanized catalytic antibody that has been used to generate various immunoconjugate species such as chemically programmed antibodies, antibody-drug conjugates, and antibody-siRNA conjugates. Highly efficient and specific conjugation of h38C2 occurs at its uniquely reactive lysine (Lys) residue buried inside the antibody's catalytic pocket. We recently reported the rational mutation of this Lys residue at position 99 in the heavy chain variable domain to an arginine (Arg) residue. The Lys99Arg mutation can be site-selectively conjugated with molecules containing a hapten-like triazolyl-phenylglyoxal (TPG) unit. Here we show that this conjugation is facilitated by the unusual pH-sensitive reactivity of the Arg99 residue, consistent with an indirectly measured p of 5.2. The Arg99/TPG conjugation holds promise to further expand the versatility of the h38C2 conjugation platform, such as for the generation of antibody conjugates with dual payloads.

摘要

单克隆抗体 h38C2 是一种人源化的催化抗体,已被用于生成各种免疫缀合物,如化学编程抗体、抗体药物偶联物和抗体-siRNA 偶联物。h38C2 高度有效地和特异性地在其独特的反应性赖氨酸(Lys)残基处发生反应,该赖氨酸残基埋藏在抗体的催化口袋内。我们最近报道了在重链可变区的位置 99 处将该 Lys 残基理性突变突变为精氨酸(Arg)残基。Lys99Arg 突变可以与含有类半抗原的三唑基-苯甘氨酸(TPG)单元的分子进行位点选择性缀合。在这里,我们表明这种缀合是由 Arg99 残基的异常 pH 敏感反应性促成的,与间接测量的 p 值为 5.2 一致。Arg99/TPG 缀合有望进一步扩展 h38C2 缀合平台的多功能性,例如生成具有双重有效载荷的抗体缀合物。

相似文献

本文引用的文献

5
Next generation antibody drugs: pursuit of the 'high-hanging fruit'.下一代抗体药物:追求“高挂的果实”。
Nat Rev Drug Discov. 2018 Mar;17(3):197-223. doi: 10.1038/nrd.2017.227. Epub 2017 Dec 1.
7
Residue-Specific Peptide Modification: A Chemist's Guide.特定残基肽修饰:化学家指南
Biochemistry. 2017 Aug 1;56(30):3863-3873. doi: 10.1021/acs.biochem.7b00536. Epub 2017 Jul 17.
8
Strategies and challenges for the next generation of antibody-drug conjugates.下一代抗体药物偶联物的策略与挑战。
Nat Rev Drug Discov. 2017 May;16(5):315-337. doi: 10.1038/nrd.2016.268. Epub 2017 Mar 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验